These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18095079)

  • 1. Levels and expressions of orotate phosphoribosyltransferase in gastric carcinoma and normal gastric mucosa tissues.
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gastric Cancer; 2007; 10(4):234-40. PubMed ID: 18095079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Orotate phosphoribosyltransferase levels in gastric carcinoma and normal gastric mucosa - correlation with thymidylate synthase and dihydropyrimidine dehydrogenase levels and the changes after neoadjuvant chemotherapy].
    Sakurai Y; Furuta S; Sunagawa R; Tonomura S; Inaba K; Shoji M; Nakamura Y; Isogaki J; Komori Y; Uyama I; Kamoshida S; Tsutsumi Y
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1581-7. PubMed ID: 17940372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: a pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens.
    Kai K; Kitajima Y; Hiraki M; Satoh S; Tanaka M; Nakafusa Y; Tokunaga O; Miyazaki K
    Cancer Lett; 2007 Dec; 258(1):45-54. PubMed ID: 17892912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and prognostic significance of protein and gene expression of orotate phosphoribosyltransferase in gastric carcinoma].
    Sakurai Y; Yoshida I; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Kamoshida S; Tsutsumi Y
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1111-8. PubMed ID: 16912530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma.
    Fujii R; Seshimo A; Kameoka S
    Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological significance of orotate phosphoribosyltransferase in gastric carcinoma].
    Sakurai Y; Yoshida I; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Kamoshida S; Tsutsumi Y
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):487-92. PubMed ID: 16612158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
    Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
    Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Komiyama H; Okano M
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):413-20. PubMed ID: 11915731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
    Oeda M; Yoshida K; Sanada Y; Wada Y; Suzuki T; Mizuiri H; Konishi K; Shigematsu H; Tanabe K; Fukushima M
    Oncol Rep; 2006 Dec; 16(6):1165-72. PubMed ID: 17089033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlated analysis of 5 fluorouracil metabolic enzymes with tumor response after SOX regimen neoadjuvant chemotherapy in advanced gastric cancer].
    Li T; Liang M; Yuan J; Guo X; Feng D; Li T; Teng D; Peng Z; Wu X; Li Z; Wang H; Chen L
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):127-30. PubMed ID: 24721353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors.
    Kaira K; Serizawa M; Koh Y; Miura S; Kaira R; Abe M; Nakagawa K; Ohde Y; Okumura T; Murakami H; Tsuya A; Nakamura Y; Naito T; Takahashi T; Kondo H; Nakajima T; Endo M; Yamamoto N
    Lung Cancer; 2011 Dec; 74(3):419-25. PubMed ID: 21550686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between clinical pathologic factors and activity of 5-FU-metabolizing enzymes in colorectal cancer.
    Yamada T; Tanaka N; Yokoi K; Seya T; Kanazawa Y; Koizumi M; Ohaki Y; Tajiri T
    J Nippon Med Sch; 2008 Feb; 75(1):23-7. PubMed ID: 18360075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of clinicopathological factors with protein expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in colorectal cancer.
    Sumi T; Katsumata K; Tsuchida A; Ishizaki T; Shimazu M; Aoki T
    Chemotherapy; 2010; 56(2):120-6. PubMed ID: 20407238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of thymidylate synthetase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activity levels in colorectal carcinoma following radical resection and administration of adjuvant 5-FU chemotherapy.
    Ishikawa M; Miyauchi T; Kashiwagi Y
    BMC Cancer; 2008 Jul; 8():188. PubMed ID: 18597678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
    Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of enzyme-linked immunosorbent assay for quantification of orotate phosphoribosyltransferase in gastric carcinoma].
    Sakurai Y; Sakamoto K; Sugimoto Y; Yoshida I; Masui T; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Matsuura S; Tanaka H; Oka T; Fukushima M
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1017-22. PubMed ID: 16044965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection of anticancer drug for poorly-differentiated adenocarcinoma of colorectum from the level of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase activities in cancer tissue].
    Takemura M; Morimura K; Yoshida K; Osugi H; Lee S; Kishida S
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1297-301. PubMed ID: 20647713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.